Skip to main content
Equibles

TATVA · Tatva Chintan Pharma Chem Limited · Financials

Use TATVA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TATVA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,685.35 INR +24.95 (+1.50%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 5468 Avg daily vol (3M) 5382

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
5.06B +32.2%
FY2026 Revenue FY2022–FY2026
Net Income
420.54M +636.1%
FY2026 Net Income FY2022–FY2026
Operating Cash Flow
314.89M +27.6%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022
INR 6.5B 5.06B 3.83B 3.94B 4.24B 4.34B
INR 401.83M 368.47M 276.59M 256.05M 95.55M 81.8M
INR 67.21M 28.51M 12.9M 65.32M 84.04M 48.32M
INR 842.96M 570.09M 75.79M 435.68M 447.79M 1.04B
INR 213.78M 149.55M 18.66M 132.14M -7.08M 82.47M
INR 629.18M 420.54M 57.13M 303.54M 454.87M 958.74M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 161.28M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.